Jill O'Donnell-Tormey
CIK: 0001927733
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHRS
Coherus Oncology, Inc.
Director
Discretionary Trading P&L
Holdings
About O'Donnell-Tormey Jill
O'Donnell-Tormey Jill (SEC CIK 0001927733) files insider reports with the SEC as Director of Coherus Oncology, Inc. (CHRS).
Signal8 holds 2 ownership filings by O'Donnell-Tormey Jill, all Form 4s, filed between Jun 13, 2025 and Jun 9, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on O'Donnell-Tormey Jill's filings is in REDWOOD CITY, CA.
Recent filings by O'Donnell-Tormey Jill
Other insiders filing for Coherus Oncology, Inc. (CHRS)
- Satvat Ali J., Director
- Karachun Rita A, Director
- Newcomer Lee Nisley, Director
- Ryan Michael Lee, Director
- Wahlstrom Mats, Director
- Newton Charles W., Director